Ventyx Biosciences to Participate in the 35th Annual Piper Sandler Healthcare Conference

Rhea-AI Summary

Ventyx Biosciences, Inc. (VTYX) executives will participate in the 35th Annual Piper Sandler Healthcare Conference on November 28, 2023, in New York, NY. The company is a clinical-stage biopharmaceutical firm focusing on advancing novel oral therapies for various inflammatory diseases with significant unmet medical needs. A webcast of the presentation will be available on the Ventyx website, with a replay available for thirty days.

SAN DIEGO, Nov. 21, 2023 (GLOBE NEWSWIRE) -- Ventyx Biosciences, Inc. (Nasdaq: VTYX) (“Ventyx”), a clinical-stage biopharmaceutical company focused on advancing novel oral therapies that address a broad range of inflammatory diseases with significant unmet medical need, today announced that Company executives will participate in the upcoming 35th Annual Piper Sandler Healthcare Conference.

• Event: 35th Annual Piper Sandler Healthcare Conference
  Location: New York, NY
  Date: Tuesday, November 28, 2023
  Time: 1:30-1:55 PM ET

A webcast of the presentation will be available in the Investors and News section of the Ventyx website at www.ventyxbio.com. A webcast replay will also be available on this website shortly after conclusion of the event for thirty days.

About Ventyx Biosciences

Ventyx is a clinical-stage biopharmaceutical company focused on developing innovative oral medicines for patients living with autoimmune and inflammatory disorders. We believe our ability to efficiently discover and develop differentiated drug candidates will allow us to address important unmet medical need with novel oral therapies that can shift immunology markets from injectable to oral drugs. Our current pipeline includes internally discovered clinical programs targeting TYK2, S1P1R and NLRP3, positioning us to become a leader in the development of oral immunology therapies. Ventyx is headquartered in San Diego, California. For more information about Ventyx, please visit www.ventyxbio.com.

Investor Relations Contact
Patti Bank
Managing Director
ICR Westwicke
(415) 513-1284
IR@ventyxbio.com

FAQ

What is Ventyx Biosciences, Inc. (VTYX) known for?

Ventyx Biosciences, Inc. (VTYX) is known for being a clinical-stage biopharmaceutical company that focuses on developing novel oral therapies for inflammatory diseases with significant unmet medical needs.

When and where will Ventyx Biosciences, Inc. (VTYX) executives participate in the 35th Annual Piper Sandler Healthcare Conference?

Ventyx Biosciences, Inc. (VTYX) executives will participate in the 35th Annual Piper Sandler Healthcare Conference on Tuesday, November 28, 2023, in New York, NY.

Where can I watch the webcast of Ventyx Biosciences, Inc. (VTYX) presentation at the 35th Annual Piper Sandler Healthcare Conference?

The webcast of Ventyx Biosciences, Inc. (VTYX) presentation at the 35th Annual Piper Sandler Healthcare Conference will be available in the Investors and News section of the Ventyx website at www.ventyxbio.com.

Will there be a webcast replay available for Ventyx Biosciences, Inc. (VTYX) presentation at the 35th Annual Piper Sandler Healthcare Conference?

Yes, a webcast replay of Ventyx Biosciences, Inc. (VTYX) presentation at the 35th Annual Piper Sandler Healthcare Conference will be available on the Ventyx website shortly after the event's conclusion for thirty days.